Global Point Of Care Testing Market PowerPoint PPT Presentations

iGATE Research has released a research report on “Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025” Click here to view the complete report: www.igateresearch.com Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.

Global Point-of-care Testing (POCT) Market By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others),By Prescription Mode (Prescription Based Testing & Over-The-Counter Testing),By Distribution Channel (Direct Tenders & Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2024

The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.

Increasing government initiatives to promote the use of Point of Care Testing products and the rise in the geriatric population are driving the demand of the market.

North America was the largest region in the home health care and residential nursing care services market in 2017, accounting for above 41% market share. The USA was the largest country in the market in 2017, accounting for above 36% market share. Read Report https://www.thebusinessresearchcompany.com/report/home-health-care-and-residential-nursing-care-services-global-market-report-2018

The global D-dimer testing market size was valued at US$ 1.23 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2021 to 2028. A paradigm shift towards the demand for next-generation point-of-care D-dimer testing is driving the global D-dimers market.The D-dimer test is used to find out if the patient is suffering from blood clotting disorder. The clotting of blood is very important, if the blood is not clotted, it may ooze out and the patient suffers from heavy blood loss.

Point-of-care coagulation testing devices market is projected to expand at a CAGR of ~6% during the forecast period, leading players in the market focus on new products with multiple modes and features, which will be more efficient and deliver a new level.

This TriMark Publications report “Point of Care Diagnostic Testing World Markets” describes latest developments in the point of care testing market segment. For more details : http://goo.gl/6pZ2p8

Point of Care Testing Market Demand Analysis and Growth Forecast from 2020 to 2026

A latest research report “Home Health Care And Residential Nursing Care Services Global Market Report” proposed by The Business Research Company provides a market summary on Market Analysis, Size, Trends and Growth. Read Full Report @ http://bit.ly/2XMvmfM Get Free Sample Copy @ http://bit.ly/2PzMtyA

Global Point of Care Diagnostics Market - Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook 2016-2026

Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.

Point-of-care Cholesterol Monitoring Device Market: Inclination Towards Portable Devices & Increasing Cholesterol Home Testing Trending the Global Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

The molecular point of care diagnostics market is estimated to grow at a CAGR of 14.05% and expected to reach $7398.82 million by 2028. Get a Free Sample Report.

Global Point of Care Diagnostics (POC) Market Analysis By Product, By Application, And Segment Forecasts To 2020 is a latest Medical Devices Industry report.

The Report on “Point of Care POC Testing Market Size, Share, Growth, Profit, Analysis, Trends and Strategy 2015" added by Research Beam Enquiry about report: http://www.researchbeam.com/2015-emerging-point-of-care-poc-testing-cancer-clinics-ambulatory-centers-surgery-centers-nursing-homes-birth-centers-supplier-shares-volume-and-sales-forecasts-for-300-tests-market/enquire-about-report

The Point of Care Diagnostic Devices Market has changed the game because earlier, a medical sample had to be sent away from the patient for hours, sometimes for days, before the results were known. During this delay, the patient has to be treated without the necessary information.

Point of care molecular diagnostics market is expected to reach a market value of USD 5.12 billion by 2027 growing at a CAGR of 12.9% in the forecast period of 2020-2027. The growing awareness regarding the testing methods among patients has been directly impacting the growth of point of care molecular diagnostics market.

Infectious Diagnostics Rapid & Point of Care Tests Pipeline Review, 2015 provides an overview of Infectious Diagnostics Rapid & Point of Care Tests currently in pipeline stage. Enquiry about report: http://www.researchbeam.com/infectious-diagnostics-rapid-and-point-of-care-tests-pipeline-review-2015-market/enquire-about-report

ResearchAarkstore Enterprise European Point of Care Diagnostic Testing Markets 

ResearchAarkstore Enterprise European Point of Care Diagnostic Testing Markets .pptx

This 340-page report contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market. Read more: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-point-of-care-poc-lipid-testing-supplier-shares-and-country-forecasts-market

Global Point of Care Technology Market Information by Product Type (Glucose Testing, Cardiac Markers, Hb1Ac Testing, Coagulation), by Instrument (Blood Glucose Meter), by End User (Clinics, Hospital, Home Care, Ambulatory Care) - Forecast to 2027

The global point of care diagnostics market was valued at US$ 17,886.3 Mn 2018 and is expected to reach US$ 30,175.3 Mn 2026, growing at a CAGR of 6.8% during the forecast period.

Visit at: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-us-point-of-care-poc-infectious-disease-testing-supplier-shares-and-country-forecasts-market Research Beam’s report on 2015-2019 Future Horizons and Growth Strategies in the US Point-of-Care/POC Infectious Disease Testing Market: Supplier Shares and Country Forecasts” contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

The point-of-care molecular diagnostics market is projected to reach US$ 5,381.18 million by 2028 from US$ 2,230.94 million in 2021; it is expected to grow at a CAGR of 13.4% from 2021 to 2028.

Data Bridge Market Research analyses that the point of care molecular diagnostics market is expected to undergo a CAGR of 13.40% during the forecast period https://www.databridgemarketresearch.com/reports/global-point-of-care-molecular-diagnostics-market

The global diabetes care devices market was valued at around $13 billion in 2017. Asia Pacific was the largest region in the diabetes care devices market in 2017, accounting for nearly 40% market share. The USA was the largest country in the market in 2017, accounting for nearly 20% market share.

Increasing incidence of infectious diseases and cancer, rising demand for diagnostics point-of-care is driving the demand for the market.

Ventilator Test Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ventilator Test Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

iGATE Research has released a research report on “Global Cardiac Marker Analyzer Market, Product Analysis, Companies Business & Marketing Strategy, Major Deals” Click here to view the complete report: https://www.igateresearch.com/global-cardiac-marker-analyzer-market-product-analysis-company-business-marketing-strategy-major-deals.html Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

The global hospitals and outpatient care centers market was valued at around $4 trillion in 2017. Asia Pacific was the largest region in the hospitals and outpatient care centers market in 2017, accounting for above 31% market share. The USA was the largest country in the market in 2017, accounting for 23% market share.

The major players covered in the global Poc Hba1C Testing Market are Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Menarini Group, F. Hoffmann-La Roche Ltd., ARKRAY Inc... @ @ https://bit.ly/3vBeLNy

The diabetes care devices market size is expected to reach nearly $35 billion in 2021 at a compound annual growth rate (CAGR) of slightly more than 7% during the forecast period. The growth in the diabetes care devices market is due to increased government initiatives to help raise awareness of diabetes and adoption of advanced technologies.

The diabetes care devices market size is expected to reach nearly $35 billion in 2021, growing at a CAGR of slightly more than 7% during the forecast period. Download A sample @ http://bit.ly/2Hg4IH8

Asia-Pacific is estimated to be the fastest growing region in "Global Diabetes Care Devices Market" analysis given by The Business Research Company. https://bit.ly/2M1bnWM

According to #TechSci Research report, Global Rapid Test Kit Market stood at USD23.44 billion in 2020 and expected to grow at steady CAGR of 8.14% by 2026. Gain More Insight: https://bit.ly/3vEVaM0 Get Sample Report: https://bit.ly/37y0udo Press Release: https://bit.ly/3rzXsfK Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/

Request a case study or sample research report @ https://precisionbusinessinsights.com/request-sample?product_id=17104 The Global Point of Care Diagnostics market size was valued at USD 27.66 billion in the year 2020 and is anticipated to record a CAGR of 3.25% during the overcast period 2021-2027. Competitive Analysis: Industry players follow some effective strategies to increase the revenue share in the market. A few of the prominent key players operating in point of care diagnostics market include Siemens AG (Germany), Abbott Laboratories, Inc.

Veterinary Point of Care Blood Gas Analyzers Market is estimated to reach $66 million by 2023, growing at a CAGR of 4.9% during the forecast period. Full report: https://kbvresearch.com/veterinary-point-of-care-blood-gas-analyzers-market/

Increasing occurrence of infectious and respiratory diseases, surging geriatric population across the globe, rising demand of home health care facilities along with advanced products, increasing expenditure from government and private institutions, growing focus on decentralised diagnosis are some of the factors that will enhance the growth of the point of care molecular diagnostics market in the forecast period of 2020-2027

Cholesterol Screening/ Cholesterol Lab Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cholesterol Screening/ Cholesterol Lab Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Major Players in the COVID-19 Rapid Test Kits Market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Quidel Corporation, BGI Genomics Read More @ https://bit.ly/2WdNIri

The major player covered in the prenatal testing and newborn screening global market report are PerkinElmer, Progenity, Laboratory Corporation of America Holdings (Sequenom), Natera. Read More @ http://bit.ly/2Kxrb6i

The Global Point Of Care Diagnostics Market size was valued for $22,975 million in 2015 and is expected to reach $43,336 million by 2022, growing at a CAGR of 9.4% from 2016 to 2022. The point of care (POC) diagnostics defined in this report are the medical devices used to get an immediate result in the investigation (diagnosis & monitoring) of various diseases such as cancer, diabetes, cardiac diseases, and others. Request sample copy of this report at: https://www.alliedmarketresearch.com/request-sample/161

Major players in the COVID-19 rapid test kits market are Thermo Fisher Scientific, Abbott Laboratories, BioMedomics, CTK Biotech, F. Hoffmann-La Roche AG, Cepheid Inc., Cellex Inc., Acumen Research Laboratories, Biolidics, and LabCorp. Read More @ https://bit.ly/3eWzfJq

A recent report published by TheBusinessResearchCompany on Point-of-Care Diagnostics Devices And Equipment Market provides in-depth analysis of segments and sub-segments in the global as well as regional. http://bit.ly/2SsaM53

Major Players in the COVID19 Rapid Test Kits Market are Thermo Fisher Scientific, Abbott Laboratories, BioMedomics, CTK Biotech, F. Hoffmann-La Roche AG, Cepheid Inc. Read More @ https://bit.ly/34gIBMr

The major players covered in the COVID19 Rapid Test Kits Global Market Report are Thermo Fisher Scientific, Abbott Laboratories, BioMedomics, CTK Biotech, F. Hoffmann-La Roche AG, Cepheid Inc., Cellex Inc., Robert Bosch GmbH, Acumen Research Laboratories, Biolidics, LabCorp, Biomaxima, Beijing Tigsun Diagnostics Co. Ltd., Getein Biotech,

Market Size - $2.4 Billion in 2015, Market Growth - CAGR of 9.5%, Market Trends – Growing demand for minimally invasive tests using specimen such as oral fluid and urine

The Business Research Company’s Diabetes Care Devices Market By Segments (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors), By Applications, By Trends And By Regions – Global Forecast To 2022 covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. http://bit.ly/33uCTn0

The research study on Global Veterinary Test kits Systems Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024 by DecisionDatabases.com analyses the complete value chain of the Industry. https://www.decisiondatabases.com/ip/39037-veterinary-test-kits-market-analysis-report

Increasing occurrence of infectious and respiratory diseases, surging geriatric population across the globe, rising demand of home health care facilities along with advanced products, increasing expenditure from government and private institutions, growing focus on decentralised diagnosis are some of the factors that will enhance the growth of the point of care molecular diagnostics market in the forecast period of 2020-2027

Point-of-Care Diagnostics Market report categories the Global market by End Users (Hospitals, Home, Ambulatory Care), Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), Over-the- Counter, Prescription Based & Geography

Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive.

A new market study based on the Point Of Care Diagnostics Market designed from various sources which also include porter's five forces analysis research techniques to explore the new opening of the market for the period of 2019-2025. The study also interrogates and examines the information based on share, market size, growth path, and the latest trends to recognize the potential value of the market. And most importantly, the data on the current business scenario will also help players to understand the stakeholder strategies and discover the new opportunities which will help them to succeed in their way.